Related Experiment Video
Updated: Jun 14, 2026
08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Finding useful biomarkers for Parkinson's disease
Alice S Chen-Plotkin1, Roger Albin2,3, Roy Alcalay4
1Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA. chenplot@pennmedicine.upenn.edu.
Science Translational Medicine
|August 17, 2018
Summary
Shared biofluid sample biorepositories and data sets are creating an ecosystem to advance Parkinson's disease biomarker research. This collaborative approach will accelerate therapeutic development and real-world patient impact.
Area of Science:
- Neuroscience
- Biomarker Discovery
- Translational Medicine
Background:
- Parkinson's disease lacks definitive biomarkers for early diagnosis and progression monitoring.
- Previous biomarker research has been fragmented, limiting progress.
- The need for standardized, accessible sample and data resources is critical.
Purpose of the Study:
- To highlight the impact of a new ecosystem of shared biofluid sample biorepositories and data sets.
- To emphasize how this ecosystem will focus biomarker efforts in Parkinson's disease.
- To underscore the potential for accelerated therapeutic development and clinical translation.
Main Methods:
- Leveraging a network of interconnected biofluid sample biorepositories.
- Utilizing shared, standardized data sets derived from these samples.
- Fostering collaborative research within this ecosystem.
Main Results:
- A concentrated focus on identifying and validating Parkinson's disease biomarkers.
- Enhanced efficiency in biomarker discovery and validation processes.
- Improved potential for translating research findings into clinical applications.
Conclusions:
- The emerging ecosystem of shared resources is poised to significantly advance Parkinson's disease biomarker research.
- This collaborative infrastructure is key to boosting the therapeutic development pipeline.
- Real-world impact through improved diagnostics and treatments is anticipated.
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...